Top

Osteoporosis International

Published in:

01-03-2021 | Original Article

Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women

Authors: L. M. Smith, J. C. Gallagher

Published in: Osteoporosis International | Issue 3/2021

Abstract

Summary

A study of 959 black and white women shows that the normal range for 24-h urine calcium excretion in white women is 30–300 mg and 10–285 mg in black women. Clinical laboratories use a normal range for 24-h urine calcium excretion of 100–300 mg; there is a need for them to update their age- and race-specific ranges.

Introduction

Recommendations for a normal range for 24-h urine calcium vary from a low of 50 mg to a high of 400 mg; most “laboratory normal ranges” based on older literature are incorrect. The objective of this analysis is to define a normal range for young women age 25–45 years and older women age 55–90 years, white and black, for 24-h urine calcium and calcium/creatinine ratio, and to examine the relationship between 24-h urine calcium, calcium absorption, and vitamin D metabolites.

Methods

Data from 3 studies was collected on 959 normal black and white women, ages 25–87 years, for 24-h urine calcium, creatinine, calcium intake, serum 25-hydroxyvitamin D (25OHD),1,25 dihydroxyvitamin D (1,25(OH)₂D), and calcium absorption. Urine calcium and creatinine were measured on an auto-analyzer. Calcium absorption was measured by a single isotope method. Serum 25OHD and 1,25(OH)₂D were measured by competitive protein binding assay or radioimmunoassay. Because 24-h urine calcium did not fit a normal distribution, non-parametric methods were used to determine the 95% reference interval (RI) and 90% non-parametric confidence intervals (CI) calculated for groups.

Results

The 95% reference intervals for 24-h urine calcium for women were as follows: black older 7–225 mg, black younger 8–285 mg; white older 37–275 mg, and white younger 23–287 mg. In older white women, 24-h urine calcium was significantly correlated with serum 1,25(OH)₂ D, r = 0.23, p < 0.001, calcium intake r = 0.12, p = 0.001, and calcium absorption r = 0.18, p = 0.003, but not serum 25OHD r = 0.07, p = 0.06.

Conclusions

The normal reference interval for 24-h urine calcium for black women is lower than white women. Twenty-four-hour urine calcium was correlated with serum 1,25(OH)₂ D calcium intake and calcium absorption, but not serum 25OHD. This range will be useful clinically for defining hypercalciuria and for following patients on vitamin D and calcium treatment.

Hodgkinson A, Pyrah LN (1958) The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 46(195):10–18. https://doi.org/10.1002/bjs.18004619504CrossRefPubMed

https://www.uclahealth.org/endocrine-center/urine-calcium-test accessed4/14/2020

Watson L, Dale NE (1966) The urinary excretion of calcium, phosphorus and creatinine in normal subjects and in patients with skin cancer. Clin Sci 31(1):77–86PubMed

Nordin BEC, Hodgkinson A, Peacock M (1967) The measurement and the meaning of urinary calcium. Clin Orthop Relat Res 52:293–322. https://doi.org/10.1097/00003086-196700520-00023CrossRefPubMed

Bulusu L, Hodgkinson A, Nordin BEC, Peacock M (1970) Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculus. Clin Sci 38(5):601–612. https://doi.org/10.1042/cs0380601CrossRefPubMed

Blackwood AM, Sagnella GA, Cook DG, Cappuccio FP (2001) Urinary calcium excretion, sodium intake and blood pressure in a multi-ethnic population: results of the Wandsworth Heart and Stroke Study. J Hum Hypertens 15(4):229–237. https://doi.org/10.1038/sj.jhh.1001171CrossRefPubMed

Davis RH, Morgan DB, Rivlin RS (1970) The excretion of calcium in the urine and its relation to calcium intake, sex and age. Clin Sci 39(1):1–12. https://doi.org/10.1042/cs0390001CrossRefPubMed

Riggs BL, O’Fallon WM, Muhs J, O’Connor MK, Kumar R, Melton LJ (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13(2):168–174. https://doi.org/10.1359/jbmr.1998.13.2.168CrossRefPubMed

Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four–hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290–2298. https://doi.org/10.1046/j.1523-1755.2001.00746.xCrossRefPubMed

10.

Meier DE, Luckey MM, Wallenstein S, Clemens TL, Orwoll ES, Waslien CI (1991) Calcium, vitamin D, and parathyroid hormone status in young white and black women: association with racial differences in bone mass*. J Clin Endocrinol Metab 72(3):703–710. https://doi.org/10.1210/jcem-72-3-703CrossRefPubMed

11.

Meier DE, Luckey MM, Wallenstein S, Lapinski RH, Catherwood B (1992) Racial differences in pre- and postmenopausal bone homeostasis: association with bone density. J Bone Miner Res 7(10):1181–1189. https://doi.org/10.1002/jbmr.5650071010CrossRefPubMed

12.

Taylor EN, Curhan GC (2007) Differences in 24-hour urine composition between black and white women. J Am Soc Nephrol 18(2):654–659. https://doi.org/10.1681/ASN.2006080854CrossRefPubMed

13.

Aloia JF, Shieh A, Mikhail M, Islam S (2015) Urinary calcium excretion in postmenopausal African American women. Clin Nephrol 84(09):130–137. https://doi.org/10.5414/CN108548CrossRefPubMedPubMedCentral

14.

Gallagher JC, Fowler SE, Detter JR, Sherman SS (2001) Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 86(8):3618–3628. https://doi.org/10.1210/jcem.86.8.7703CrossRefPubMed

15.

Gallagher JC, Sai A, Templin T, Smith L (2012) Dose response to vitamin D supplementation in postmenopausal women. Ann Intern Med 156(6):425. https://doi.org/10.7326/0003-4819-156-6-201203200-00005CrossRefPubMed

16.

Gallagher JC, Yalamanchili V, Smith LM (2012) The effect of vitamin D on calcium absorption in older women. J Clin Endocrinol Metab 97(10):3550–3556. https://doi.org/10.1210/jc.2012-2020CrossRefPubMedPubMedCentral

17.

Gallagher JC, Peacock M, Yalamanchili V, Smith LM (2013) Effects of vitamin D supplementation in older African American women. J Clin Endocrinol Metab 98(3):1137–1146. https://doi.org/10.1210/jc.2012-3106CrossRefPubMedPubMedCentral

18.

Gallagher JC, Jindal PS, Smith LM (2014) Vitamin D supplementation in young white and African American women. J Bone Miner Res 29(1):173–181. https://doi.org/10.1002/jbmr.2010CrossRefPubMed

19.

Geffré A, Friedrichs K, Harr K, Concordet D, Trumel C, Braun J-P (2009) Reference values: a review. Vet Clin Pathol 38(3):288–298. https://doi.org/10.1111/j.1939-165X.2009.00179.xCrossRefPubMed

20.

Gallagher JC, Jindal PS, Smith LM (2014) Vitamin D does not increase calcium absorption in young women: a randomized clinical trial. J Bone Miner Res 29(5):1081–1087. https://doi.org/10.1002/jbmr.2121CrossRefPubMed

21.

Cosman F, Morgan DC, Nieves JW, Shen V, Luckey MM, Dempster DW, Lindsay R, Parisien M (1997) Resistance to bone resorbing effects of PTH in black women. J Bone Miner Res 12(6):958–966. https://doi.org/10.1359/jbmr.1997.12.6.958CrossRefPubMed

22.

Smith LM, Gallagher JC (2019) Effect of vitamin D supplementation on total and free 25 hydroxyvitamin D and parathyroid hormone. An analysis of two randomized controlled trials. J Intern Med 286(6):651–659. https://doi.org/10.1111/joim.12950CrossRefPubMedPubMedCentral

23.

Seeger H, Kaelin FPM, Weber D et al (2017) Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers. BMC Nephrol 18(1):349, 2-9. https://doi.org/10.1186/s12882-017-0755-7CrossRefPubMedPubMedCentral

24.

Bayomy O, Zaheer S, Williams JS, Curhan G, Vaidya A (2020) Disentangling the relationships between the renin-angiotensin-aldosterone system, calcium physiology, and risk for kidney stones. J Clin Endocrinol Metab 105(6):1937–1946. https://doi.org/10.1210/clinem/dgaa123CrossRef

25.

Sai AJ, Walters RW, Fang X, Gallagher JC (2011) Relationship between vitamin D, parathyroid hormone, and bone health. J Clin Endocrinol Metab 96(3):E436–E446. https://doi.org/10.1210/jc.2010-1886CrossRefPubMed

26.

Gallagher JC, Smith LM, Yalamanchili V (2014) Incidence of hypercalciuria and hypercalcemia during vitamin D and calcium supplementation in older women. Menopause 21(11):1173–1180. https://doi.org/10.1097/GME.0000000000000270CrossRefPubMedPubMedCentral

27.

Jackson RD, LaCroix AZ, Gass M et al (2006) Women’s health initiative investigators. Calcium plus vitamin D and the risk of fractures. N Engl J Med 354:669–683CrossRef

28.

Bailey RL, Dodd KW, Goldman JA, Gahche JJ, Dwyer JT, Moshfegh AJ, Sempos CT, Picciano MF (2010) Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 140(4):817–822. https://doi.org/10.3945/jn.109.118539CrossRefPubMedPubMedCentral

29.

Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ (1997) Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 126(7):497–504. https://doi.org/10.7326/0003-4819-126-7-199704010-00001CrossRefPubMed

Title: Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women
Authors: L. M. Smith
J. C. Gallagher
Publication date: 01-03-2021
Publisher: Springer London
Published in: Osteoporosis International / Issue 3/2021
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-020-05615-6

At a glance: The STEP trials

Springer Medicine

Reference range for 24-h urine calcium, calcium/creatinine ratio, and correlations with calcium absorption and serum vitamin D metabolites in normal women

Abstract

Summary

Introduction

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2021

Efficiency of coordinator-based osteoporosis intervention in fragility fracture patients: a prospective randomized trial

Denosumab is not associated with risk of malignancy: systematic review and meta-analysis of randomized controlled trials

Correction to: Real-world bone turnover marker use: impact on treatment decisions and fracture

Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome

Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden

Five-year follow-up results of aerobic and impact training on bone mineral density in early breast cancer patients